| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Paul Hodgkins, Monica Shaw, Suzanne McCarthy, Floyd R Salle. The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter? CNS drugs. vol 26. issue 3. 2012-06-12. PMID:22329564. |
the pharmacology and clinical outcomes of amphetamines to treat adhd: does composition matter? |
2012-06-12 |
2023-08-12 |
Not clear |
| Ann C Childress, Sally A Berr. Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents. Drugs. vol 72. issue 3. 2012-05-03. PMID:22316347. |
stimulants (amphetamines and methylphenidates) and nonstimulants (atomoxetine, guanfacine extended-release (xr) and clonidine xr) have been found to be effective and are approved by the us fda for the treatment of adhd in adolescents in the us. |
2012-05-03 |
2023-08-12 |
Not clear |
| F Xavier Castellanos, M Teresa Acost. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder]. Revista de neurologia. vol 52 Suppl 1. 2012-01-05. PMID:21365598. |
methylphenidate and the amphetamines are the most frequently used medications for treating attention-deficit/hyperactivity disorder (adhd). |
2012-01-05 |
2023-08-12 |
Not clear |
| José Augusto Cabral Barro. [New tendencies in medicalization]. Ciencia & saude coletiva. vol 13 Suppl. 2011-11-08. PMID:21936162. |
special emphasis was given to the irrational use of amphetamines to diminish the appetite and to control weight or to treat children supposedly suffering from attention-deficit hyperactivity disorder (adhd) as well as to drugs used in cases of depression and supposed andropause. |
2011-11-08 |
2023-08-12 |
Not clear |
| Xavier Castells, Josep Antoni Ramos-Quiroga, Rosa Bosch, Mariana Nogueira, Miguel Casa. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. The Cochrane database of systematic reviews. issue 6. 2011-08-24. PMID:21678370. |
amphetamines for attention deficit hyperactivity disorder (adhd) in adults. |
2011-08-24 |
2023-08-12 |
Not clear |
| Xavier Castells, Josep Antoni Ramos-Quiroga, Rosa Bosch, Mariana Nogueira, Miguel Casa. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. The Cochrane database of systematic reviews. issue 6. 2011-08-24. PMID:21678370. |
amphetamines are used to treat adult adhd, but uncertainties persist about their efficacy and safety. |
2011-08-24 |
2023-08-12 |
Not clear |
| G Cunniffe, R Murthy, B Beig. Attention deficit hyperactivity disorder: diagnosis and treatment masking the ophthalmic clinical presentation of a pineal gland tumour in a teenager. International ophthalmology. vol 30. issue 6. 2011-03-28. PMID:20225001. |
he was diagnosed with attention deficit hyperactivity disorder (adhd) 3 years earlier and treated with amphetamines. |
2011-03-28 |
2023-08-12 |
Not clear |
| A G Franke, K Lie. [Pharmacological neuroenhancement and brain doping : Chances and risks]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. vol 53. issue 8. 2011-01-14. PMID:20700786. |
this subcategory includes psychostimulants (e.g., amphetamines, methylphenidate), modafinil, antidementia drugs (acetylcholine-esterase inhibitors, memantine), and antidepressants (selective serotonin reuptake inhibitors) which are being prescribed for the treatment of adhd (attention deficit/hyperactivity disorder), alzheimer's disease, and depression. |
2011-01-14 |
2023-08-12 |
human |
| Sean Hennessy, Hedi Schelleman, Gregory W Daniel, Warren B Bilker, Stephen E Kimmel, James Guevara, Mark J Cziraky, Brian L Stro. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study. Pharmacoepidemiology and drug safety. vol 19. issue 9. 2010-12-13. PMID:20623519. |
to describe the design and rationale of an investigator-initiated observational study to examine the cardiovascular safety of the following commonly-used medications to treat attention deficit hyperactivity disorder (adhd): amphetamines, methylphenidate, and atomoxetine. |
2010-12-13 |
2023-08-12 |
Not clear |
| Margaret D Weiss, Christopher Gibbins, David W Goodman, Paul S Hodgkins, Jeanne M Landgraf, Stephen V Faraon. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. The Journal of clinical psychiatry. vol 71. issue 4. 2010-04-30. PMID:20361900. |
study was designed to evaluate effectiveness of long-acting amphetamines in adults with attention-deficit/hyperactivity disorder (adhd) in community practice settings. |
2010-04-30 |
2023-08-12 |
Not clear |
| S M Berman, R Kuczenski, J T McCracken, E D Londo. Potential adverse effects of amphetamine treatment on brain and behavior: a review. Molecular psychiatry. vol 14. issue 2. 2009-04-08. PMID:18698321. |
although they have long been used effectively to treat attention deficit hyperactivity disorder (adhd) in children and adolescents, amphetamines are now being prescribed increasingly as maintenance therapy for adhd and narcolepsy in adults, considerably extending the period of potential exposure. |
2009-04-08 |
2023-08-12 |
human |
| Paul G Overto. Collicular dysfunction in attention deficit hyperactivity disorder. Medical hypotheses. vol 70. issue 6. 2008-08-13. PMID:18215471. |
the current front-line pharmacotherapies for the treatment of adhd, namely the psychostimulants methylphenidate and amphetamines, have clear abuse potential, hence there is a strong need to develop new drug treatments for this disorder. |
2008-08-13 |
2023-08-12 |
rat |
| J D Gowan, V Coizet, I M Devonshire, P G Overto. D-amphetamine depresses visual responses in the rat superior colliculus: a possible mechanism for amphetamine-induced decreases in distractibility. Journal of neural transmission (Vienna, Austria : 1996). vol 115. issue 3. 2008-07-01. PMID:18301956. |
amphetamines can enhance sustained attention, and reduce distractibility, in normal subjects and patients with attentional-deficit/hyperactivity disorder (adhd). |
2008-07-01 |
2023-08-12 |
human |
| Alcy R Torres, Jane Whitney, Joseph Gonzalez-Heydric. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy & behavior : E&B. vol 12. issue 2. 2008-03-18. PMID:18065271. |
preclinical, retrospective and open-label studies on amphetamines and atomoxetine support undertaking randomized controlled studies of these agents in patients with adhd plus epilepsy. |
2008-03-18 |
2023-08-12 |
human |
| Stephen V Faraon. Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release). Expert opinion on pharmacotherapy. vol 8. issue 13. 2007-09-17. PMID:17714065. |
the efficacy of amphetamines in the management of attention-deficit/hyperactivity disorder (adhd) is well established. |
2007-09-17 |
2023-08-12 |
Not clear |
| Frank A Lópe. ADHD: new pharmacological treatments on the horizon. Journal of developmental and behavioral pediatrics : JDBP. vol 27. issue 5. 2007-01-29. PMID:17041279. |
the stimulants methylphenidate and amphetamines have been used for decades as first-line therapy for the treatment of adhd. |
2007-01-29 |
2023-08-12 |
Not clear |
| P N J Langendijk, A A M Wild. [Medication for ADHD and the risk of cardiovascular mortality]. Nederlands tijdschrift voor geneeskunde. vol 150. issue 31. 2006-09-11. PMID:16924941. |
recently, the fda recommended a black-box warning describing the increased risk of cardiovascular events associated with the use of stimulant drugs (amphetamines; in the netherlands: dexamphetamine, methylphenidate) in the treatment of attention deficit hyperactivity disorder (adhd). |
2006-09-11 |
2023-08-12 |
Not clear |
| Donald E Greydanu. Pharmacologic treatment of attention-deficit hyperactivity disorder. Indian journal of pediatrics. vol 72. issue 11. 2006-07-11. PMID:16391451. |
various preparations of methylphenidate and amphetamines have been used for a long time in the treatment of adhd. |
2006-07-11 |
2023-08-12 |
Not clear |
| G M Levi. Attention-deficit hyperactivity disorder: the pharmacist's role. American pharmacy. vol NS35. issue 11. 1996-01-29. PMID:8533716. |
of the medications discussed here, the stimulants are recognized as the most effective for treating adhd, with the amphetamines and methylphenidate providing equal benefit. |
1996-01-29 |
2023-08-12 |
Not clear |